Correlation Between Pfizer and Organon
Can any of the company-specific risk be diversified away by investing in both Pfizer and Organon at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Organon into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Organon Co, you can compare the effects of market volatilities on Pfizer and Organon and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Organon. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Organon.
Diversification Opportunities for Pfizer and Organon
Poor diversification
The 3 months correlation between Pfizer and Organon is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Organon Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Organon and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Organon. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Organon has no effect on the direction of Pfizer i.e., Pfizer and Organon go up and down completely randomly.
Pair Corralation between Pfizer and Organon
Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.64 times more return on investment than Organon. However, Pfizer Inc is 1.56 times less risky than Organon. It trades about -0.23 of its potential returns per unit of risk. Organon Co is currently generating about -0.2 per unit of risk. If you would invest 2,842 in Pfizer Inc on August 27, 2024 and sell it today you would lose (225.00) from holding Pfizer Inc or give up 7.92% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pfizer Inc vs. Organon Co
Performance |
| Timeline |
| Pfizer Inc |
| Organon |
Pfizer and Organon Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pfizer and Organon
The main advantage of trading using opposite Pfizer and Organon positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Organon can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Organon will offset losses from the drop in Organon's long position.| Pfizer vs. Capricor Therapeutics | Pfizer vs. Soleno Therapeutics | Pfizer vs. Bio Path Holdings | Pfizer vs. Moleculin Biotech |
| Organon vs. Johnson Johnson | Organon vs. Bristol Myers Squibb | Organon vs. AbbVie Inc | Organon vs. Eli Lilly and |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |